Curcumin Supports Postpartum Mental Health In First-Time Mothers

A recent clinical trial published in BMC Complementary Medicine and Therapies explored whether curcumin—a compound found in turmeric—can help alleviate postpartum depression and anxiety in first-time mothers, known as primiparous women. Postpartum depression and anxiety are common conditions that can interfere with maternal bonding and overall well-being, yet treatment options for breastfeeding mothers are often limited.

In this double-blind, placebo-controlled study, 96 primiparous women in Tabriz, Iran, were randomly assigned to receive either 500 mg of curcumin or a placebo daily for eight weeks. Researchers assessed participants' mental health using two standard tools: the Edinburgh Postnatal Depression Scale (EPDS) and the Postpartum Specific Anxiety Scale – Research Short Form (PSAS-RSF). By the end of the study, the curcumin group showed significant reductions in both depression and anxiety scores compared to the placebo group.

Curcumin is known for its anti-inflammatory and antioxidant properties and has been studied for its potential mood-regulating effects. In this trial, it was well-tolerated, with only a few participants reporting mild gastrointestinal discomfort. Given its accessibility and safety profile, curcumin may offer a promising complementary approach to support mental health in new mothers.